Elżbieta Trylińska

Recent publications · Crossref

5 total works indexed

1. Olaparib for Metastatic Breast Cancer in Patients with a Germline <i>BRCA</i> Mutation

   · 2017 · cited 2,836x

2. 2023 ESC Guidelines for the management of cardiomyopathies

   · 2023 · cited 2,251x

3. Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

   · 2012 · cited 2,004x

4. Adjuvant Olaparib for Patients with <i>BRCA1</i> - or <i>BRCA2</i> -Mutated Breast Cancer

   · 2021 · cited 1,472x

5. Heterocyclic Nanographenes and Other Polycyclic Heteroaromatic Compounds: Synthetic Routes, Properties, and Applications

   · 2016 · cited 1,335x

via Crossref · CC0